Interaction of botulinum type A, B and E derivative toxins with synaptosomes of rat brain
- PMID: 492355
- DOI: 10.1007/BF00499721
Interaction of botulinum type A, B and E derivative toxins with synaptosomes of rat brain
Abstract
Clostridium botulimum 125I-labelled derivative toxin immediately bound to rat synaptosomes. Of the two fragments of type B derivative toxin, the large-molecular-weight fragment (fragment I) inhibited the binding of labelled type B derivative toxin to synaptosomes in the same manner as unlabelled type B toxin did. The inhibition by the small-molecular-weight fragment (fragment II) was less than that by fragment I. These findings suggest that type B toxin binds to synaptosomes mainly with some part of fragment I. The binding of labelled type A and E derivative toxins was inhibited by either of the unlabelled type A or E derivative toxins, but not by type B derivative toxin. It is concluded that synaptosomes of rat brain possess relatively specific binding sites for botulinum toxin types.
Similar articles
-
Binding to mouse brain synaptosomes of Clostridium botulinum type E derivative toxin before and after tryptic activation.Toxicon. 1982;20(5):841-6. doi: 10.1016/0041-0101(82)90071-x. Toxicon. 1982. PMID: 7179292
-
Affinity chromatography of tetanus toxin, tetanus toxoid, and botulinum A toxin on synaptosomes, and differentiation of their acceptors.Naunyn Schmiedebergs Arch Pharmacol. 1976;293(1):1-9. doi: 10.1007/BF00498864. Naunyn Schmiedebergs Arch Pharmacol. 1976. PMID: 948349
-
Comparison of Clostridium botulinum toxins type D and C1 in molecular property, antigenicity and binding ability to rat-brain synaptosomes.Eur J Biochem. 1984 Aug 1;142(3):487-92. doi: 10.1111/j.1432-1033.1984.tb08312.x. Eur J Biochem. 1984. PMID: 6468375
-
Action of botulinum neurotoxin on acetylcholine release from rat brain synaptosomes: putative internalization of the toxin into synaptosomes.J Biochem. 1987 Dec;102(6):1355-64. doi: 10.1093/oxfordjournals.jbchem.a122181. J Biochem. 1987. PMID: 3129413
-
Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacology.Dis Mon. 2002 May;48(5):367-83. doi: 10.1053/mda.2001.24421. Dis Mon. 2002. PMID: 12195266 Review.
Cited by
-
Binding of Clostridium botulinum type C neurotoxin to different neuroblastoma cell lines.Infect Immun. 1989 Jan;57(1):272-7. doi: 10.1128/iai.57.1.272-277.1989. Infect Immun. 1989. PMID: 2535834 Free PMC article.
-
The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin.Infect Immun. 1986 Jun;52(3):786-91. doi: 10.1128/iai.52.3.786-791.1986. Infect Immun. 1986. PMID: 2423459 Free PMC article.
-
Botulinum neurotoxin - from laboratory to bedside.Neurotox Res. 2006 Apr;9(2-3):133-40. doi: 10.1007/BF03033931. Neurotox Res. 2006. PMID: 16785110 Review.
-
Botulinum type F neurotoxin. Large-scale purification and characterization of its binding to rat cerebrocortical synaptosomes.Biochem J. 1990 May 15;268(1):123-8. doi: 10.1042/bj2680123. Biochem J. 1990. PMID: 2188647 Free PMC article.
-
Immunological characterization of papain-induced fragments of Clostridium botulinum type A neurotoxin and interaction of the fragments with brain synaptosomes.Infect Immun. 1989 Sep;57(9):2634-9. doi: 10.1128/iai.57.9.2634-2639.1989. Infect Immun. 1989. PMID: 2668181 Free PMC article.